Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 276,000 shares at $5.65 ($1.5M) on 2018-10-11, disclosed to the SEC on 2018-10-15.
Open-market sale of $1.5M TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.65 | 92,000 | $520K | 33.7% |
| 2 | $5.65 | 92,000 | $520K | 33.7% |
| 3 | $5.45 | 92,000 | $501K | 32.5% |
| Total | $5.58 avg | 276,000 | $1.5M | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |